Real-time Estimate
Cboe BZX
09:35:50 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
23.62
USD
|
-1.60%
|
|
+7.38%
|
-21.34%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,309
|
4,694
|
5,330
|
1,943
|
1,268
|
1,008
|
-
|
-
|
Enterprise Value (EV)
1 |
1,309
|
4,694
|
5,330
|
1,943
|
1,268
|
1,008
|
1,008
|
1,008
|
P/E ratio
|
-749
x
|
-748
x
|
-148
x
|
-43.2
x
|
-28.3
x
|
-55.8
x
|
308
x
|
-960
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.41
x
|
9.35
x
|
7.62
x
|
2.15
x
|
1.14
x
|
0.8
x
|
0.73
x
|
0.69
x
|
EV / Revenue
|
3.41
x
|
9.35
x
|
7.62
x
|
2.15
x
|
1.14
x
|
0.8
x
|
0.73
x
|
0.69
x
|
EV / EBITDA
|
124
x
|
408
x
|
1,126
x
|
2,615
x
|
197
x
|
33
x
|
20.5
x
|
16.9
x
|
EV / FCF
|
121
x
|
-
|
-1,088
x
|
-77.5
x
|
3,541
x
|
25.5
x
|
15.3
x
|
9.75
x
|
FCF Yield
|
0.82%
|
-
|
-0.09%
|
-1.29%
|
0.03%
|
3.92%
|
6.55%
|
10.3%
|
Price to Book
|
-
|
-
|
16.1
x
|
6.55
x
|
4.16
x
|
3.43
x
|
3.3
x
|
3.79
x
|
Nbr of stocks (in thousands)
|
34,947
|
39,215
|
40,368
|
40,884
|
41,545
|
41,995
|
-
|
-
|
Reference price
2 |
37.46
|
119.7
|
132.0
|
47.53
|
30.51
|
24.00
|
24.00
|
24.00
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
383.9
|
502
|
699
|
905.2
|
1,109
|
1,256
|
1,377
|
1,471
|
EBITDA
1 |
10.58
|
11.51
|
4.734
|
0.743
|
6.434
|
30.53
|
49.09
|
59.55
|
EBIT
1 |
-1.92
|
-4.927
|
-35.2
|
-43
|
-40.66
|
-13.61
|
5.763
|
8.967
|
Operating Margin
|
-0.5%
|
-0.98%
|
-5.04%
|
-4.75%
|
-3.67%
|
-1.08%
|
0.42%
|
0.61%
|
Earnings before Tax (EBT)
1 |
-1.64
|
-5.727
|
-35.22
|
-44.2
|
-45.04
|
-18.23
|
5.118
|
-1.25
|
Net income
1 |
-1.809
|
-5.84
|
-35.53
|
-44.67
|
-44.69
|
-18.12
|
3.461
|
-1.3
|
Net margin
|
-0.47%
|
-1.16%
|
-5.08%
|
-4.94%
|
-4.03%
|
-1.44%
|
0.25%
|
-0.09%
|
EPS
2 |
-0.0500
|
-0.1600
|
-0.8900
|
-1.100
|
-1.080
|
-0.4300
|
0.0780
|
-0.0250
|
Free Cash Flow
1 |
10.78
|
-
|
-4.897
|
-25.09
|
0.358
|
39.5
|
66.01
|
103.4
|
FCF margin
|
2.81%
|
-
|
-0.7%
|
-2.77%
|
0.03%
|
3.15%
|
4.79%
|
7.03%
|
FCF Conversion (EBITDA)
|
101.91%
|
-
|
-
|
-
|
5.56%
|
129.38%
|
134.45%
|
173.58%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
1,907.33%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
181.7
|
194.4
|
206
|
219.4
|
233.8
|
246
|
256.3
|
270.6
|
285.9
|
295.9
|
300.6
|
308.1
|
318.9
|
328
|
331
|
EBITDA
1 |
2.17
|
3.499
|
1.178
|
-1.666
|
-0.943
|
2.175
|
-4.869
|
-3.242
|
6.058
|
8.487
|
4.661
|
5.819
|
8.321
|
11.71
|
10.42
|
EBIT
1 |
-7.192
|
-5.763
|
-9.114
|
-12.77
|
-11.9
|
-9.217
|
-24.49
|
-13.09
|
-3.491
|
0.408
|
-6.65
|
-5.097
|
-2.399
|
0.423
|
-1.097
|
Operating Margin
|
-3.96%
|
-2.96%
|
-4.42%
|
-5.82%
|
-5.09%
|
-3.75%
|
-9.55%
|
-4.84%
|
-1.22%
|
0.14%
|
-2.21%
|
-1.65%
|
-0.75%
|
0.13%
|
-0.33%
|
Earnings before Tax (EBT)
1 |
-7.131
|
-6.008
|
-8.879
|
-13.6
|
-12.42
|
-9.3
|
-24.97
|
-13.95
|
-4.079
|
-2.033
|
-8.345
|
-6.641
|
-4.083
|
-1.466
|
-4.406
|
Net income
1 |
-6.819
|
-7.042
|
-8.855
|
-13.62
|
-12.91
|
-9.285
|
-24.78
|
-13.71
|
-4.036
|
-2.163
|
-8.023
|
-6.104
|
-3.328
|
-0.6298
|
-4.034
|
Net margin
|
-3.75%
|
-3.62%
|
-4.3%
|
-6.21%
|
-5.52%
|
-3.77%
|
-9.67%
|
-5.07%
|
-1.41%
|
-0.73%
|
-2.67%
|
-1.98%
|
-1.04%
|
-0.19%
|
-1.22%
|
EPS
2 |
-0.1700
|
-0.1700
|
-0.2200
|
-0.3300
|
-0.3200
|
-0.2300
|
-0.6000
|
-0.3300
|
-0.1000
|
-0.0500
|
-0.1957
|
-0.1471
|
-0.0757
|
-0.0157
|
-0.0550
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/3/21
|
2/16/22
|
4/28/22
|
8/3/22
|
11/3/22
|
2/15/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/15/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
10.8
|
-
|
-4.9
|
-25.1
|
0.36
|
39.5
|
66
|
103
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-10.6%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-6.7%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
530.4
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
8.210
|
7.260
|
7.330
|
7.000
|
7.270
|
6.340
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
5.37
|
-
|
12.4
|
17.1
|
-
|
-
|
-
|
-
|
Capex / Sales
|
1.4%
|
-
|
1.77%
|
1.89%
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/16/22
|
2/15/23
|
2/15/24
|
-
|
-
|
-
|
Average target price
35.67
USD Spread / Average Target +48.61% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.34% | 1.01B | | +11.81% | 9.51B | | 0.00% | 6.5B | | +90.16% | 4.12B | | +0.81% | 2.39B | | +2.95% | 876M | | +83.33% | 739M | | +3.52% | 155M | | -6.42% | 70.04M |
Health Insurance
|